{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:29:59Z","timestamp":1793712599868,"version":"4.6.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Historically prominent in Ayurvedic cultures, turmeric (\n                    <jats:italic>Curcuma longa<\/jats:italic>\n                    ), or \u201cHaldi,\u201d is renowned for its anti-inflammatory and antioxidant effects, mainly due to its active compounds, curcuminoids. Due to the increasing use of turmeric supplements, this study critically examined 125 preparations across the UK, USA, India, Australia, and Germany and evaluated their compliance with evidence-based recommendations. Results reveal significant regulatory and labeling inconsistencies across countries, with 34% of preparations failing to disclose the active curcuminoid content. This lack of dosage regulation is especially concerning when considering the ongoing research into advanced delivery systems\u2014such as nanoparticles, liposomes, micelles, and phospholipid complexes\u2014which significantly enhance curcumin\u2019s absorption. Curcumin, a hydrophobic compound,  undergoes\u00a0rapid metabolism in the liver through Phase I and II detoxification pathways, particularly via cytochrome P450 enzymes and UDP-glucuronosyltransferase enzymes. This results in limited\u00a0bioavailability, as curcumin is rapidly converted to water-soluble metabolites and excreted, reducing its effectiveness at therapeutic doses. However, through modern formulation technologies, curcumin can potentially not only alter drug metabolism, but its antioxidant action via Nrf2 activation can shift to pro-oxidant effects at high doses, causing oxidative stress and the accumulation of reactive metabolites. Emerging evidence suggests chronic low-dose use may lead to gastrointestinal, hepatic, or renal toxicity, yet turmeric preparations, falling within the scope of food law, lack the stringent controls applied to pharmaceuticals and are generally assumed safe. This study highlights the need for transparent labeling, clear dosage guidelines, and an understanding of curcumin\u2019s metabolic profile to guide consumers in maximizing benefits while mitigating risks. Furthermore, it aims to assist healthcare professionals in making informed recommendations regarding curcumin supplementation. Further research must include long-term clinical trials and potential standardization of curcumin supplement formulations.\n                  <\/jats:p>","DOI":"10.1007\/s00210-025-04392-5","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T10:15:20Z","timestamp":1754561720000},"page":"1315-1346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A market and risk assessment of 125 turmeric supplements available in Australia, Germany, India, UK, and USA"],"prefix":"10.1007","volume":"399","author":[{"given":"Haleema","family":"Rahim-Mahdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"4392_CR1","unstructured":"21 CFR \u00a7101.17. U.S. Food and Drug Administration (2023) CFR \u2013 code of Federal Regulations Title 21. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=101.17. Accessed 26 03 2024"},{"key":"4392_CR2","unstructured":"21 CFR \u00a7321(ff)(3)(b)(2). U.S. Food and Drug Administration (2023) CFR \u2013 code of Federal Regulations Title 21. Accessed on 17.03.2024. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=1&showFR=1"},{"key":"4392_CR3","unstructured":"21 CFR \u00a7101.93. U.S. Food and Drug Administration (2023) CFR \u2013 code of Federal Regulations Title 21.https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-B\/part-101\/subpart-F\/section-101.93. Accessed on 27 03 2024"},{"key":"4392_CR4","unstructured":"21 CFR \u00a7101.36. U.S. Food and Drug Administration (2023) CFR \u2013 code of Federal Regulations Title 21. https:\/\/www.ecfr.gov\/current\/title-21\/part-101\/section-101.36#p-101.36(a).Accessed 2 04 2024"},{"issue":"10","key":"4392_CR5","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1002\/jsfa.11372","volume":"101","author":"ME Abd El-Hack","year":"2021","unstructured":"Abd El-Hack et al (2021) Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. J Sci Food Agric 101(10):3946\u20133959. https:\/\/doi.org\/10.1002\/jsfa.11372","journal-title":"J Sci Food Agric"},{"issue":"1","key":"4392_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3892\/mmr.2015.4579","volume":"13","author":"ML Aggarwal","year":"2016","unstructured":"Aggarwal et al (2016) Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: a bioavailable turmeric formulation. Mol Med Rep 13(1):592\u2013604. https:\/\/doi.org\/10.3892\/mmr.2015.4579","journal-title":"Mol Med Rep"},{"key":"4392_CR7","doi-asserted-by":"publisher","unstructured":"Ahmad et al (2020) Biochemistry, safety, pharmacological activities, and clinical applications of turmeric: a mechanistic review. Evid-Based Complement Alternat Med Article 7656919 https:\/\/doi.org\/10.1155\/2020\/7656919","DOI":"10.1155\/2020\/7656919"},{"key":"4392_CR8","unstructured":"Akay Group. (n.d.) Natural and clean-label curcumin. https:\/\/www.akay-group.com\/index.php\/natural-and-clean-label-curcumin. Accessed 8 Jun 2025"},{"issue":"10","key":"4392_CR9","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1089\/jmf.2017.3930","volume":"20","author":"A Amalraj","year":"2017","unstructured":"Amalraj et al (2017) A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients. J Med Food 20(10):1022\u20131030. https:\/\/doi.org\/10.1089\/jmf.2017.3930","journal-title":"J Med Food"},{"key":"4392_CR10","unstructured":"ANSES (2022) Adverse effects associated with the consumption of food supplements containing turmeric. Anses - Agence Nationale de S\u00e9curit\u00e9 Sanitaire de l\u2019Alimentation, de l\u2019Environnement et Du Travail, www.anses.fr\/en\/content\/adverse-effects-associated-consumption-food-supplements-containing-turmeric#:~:text=ANSES%20advises%20some%20individuals%20not%20to%20consome%20these%20products&text=As%20it%20does%20for%20all. Accessed 2 04 2023"},{"issue":"4","key":"4392_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4103\/0250-474X.44591","volume":"70","author":"B Antony","year":"2008","unstructured":"Antony et al (2008) A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci 70(4):445\u2013449. https:\/\/doi.org\/10.4103\/0250-474X.44591","journal-title":"Indian J Pharm Sci"},{"key":"4392_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2017.07.022","volume":"209","author":"R Bahramsoltani","year":"2017","unstructured":"Bahramsoltani R et al (2017) Pharmacokinetic interactions of curcuminoids with conventional drugs: a review. J Ethnopharmacol 209:1\u201312. https:\/\/doi.org\/10.1016\/j.jep.2017.07.022","journal-title":"J Ethnopharmacol"},{"key":"4392_CR13","doi-asserted-by":"publisher","unstructured":"Bandyopadhyay D (2014) Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer. Front Chem 2. https:\/\/doi.org\/10.3389\/fchem.2014.00113","DOI":"10.3389\/fchem.2014.00113"},{"key":"4392_CR14","unstructured":"Bejar E (2018) Adulteration of turmeric (Curcuma longa) root and rhizome, and root and rhizome extracts. https:\/\/www.researchgate.net\/profile\/Ezra-Bejar\/publication\/325617460_Adulteration_of_turmeric_Curcuma_longa_root_and_rhizome_and_root_and_rhizome_extracts\/links\/5b18b578a6fdcca67b62aa9f\/Adulteration-of-turmeric-Curcuma-longa-root-and-rhizome-and-root-and-rhizome-extracts.pdf. Accessed 17 4 2024"},{"issue":"4","key":"4392_CR15","first-page":"337","volume":"15","author":"G Belcaro","year":"2010","unstructured":"Belcaro G et al (2010) Efficacy and safety of Meriva\u00ae, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev 15(4):337\u2013344","journal-title":"Altern Med Rev"},{"key":"4392_CR16","unstructured":"Bethesda (2024) Turmeric, LiverTox: clinical and research information on drug-induced liver injury [Internet]. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548561\/"},{"issue":"2","key":"4392_CR17","first-page":"161","volume":"8","author":"AC Bharti","year":"2010","unstructured":"Bharti AC et al (2010) Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: an in vitro analysis. J Clin Immunol 8(2):161\u2013171","journal-title":"J Clin Immunol"},{"key":"4392_CR18","doi-asserted-by":"publisher","unstructured":"Bundesinstitut f\u00fcr Risikobewertung (BfR) (2021). Curcumin in food supplements: acceptable daily intake may be exceeded: BfR Opinion No 040\/2021 of 14 December 2021, BfR-Stellungnahmen. Bundesinst. f\u00fcr Risikobewertung. https:\/\/doi.org\/10.17590\/20211221-123422","DOI":"10.17590\/20211221-123422"},{"issue":"7","key":"4392_CR19","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/ijc.24967","volume":"126","author":"E Burgos-Mor\u00f3n","year":"2010","unstructured":"Burgos-Mor\u00f3n E et al (2010) The dark side of curcumin. Int J Cancer 126(7):1771\u20135. https:\/\/doi.org\/10.1002\/ijc.24967","journal-title":"Int J Cancer"},{"issue":"5","key":"4392_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jaad.2011.04.022","volume":"66","author":"N Chainani-Wu","year":"2012","unstructured":"Chainani-Wu N et al (2012) High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. J Am Acad Dermatol 66(5):752\u2013760. https:\/\/doi.org\/10.1016\/j.jaad.2011.04.022","journal-title":"J Am Acad Dermatol"},{"issue":"4B","key":"4392_CR21","first-page":"2895","volume":"21","author":"AL Cheng","year":"2001","unstructured":"Cheng AL et al (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21(4B):2895\u20132900","journal-title":"Anticancer Res"},{"key":"4392_CR22","unstructured":"Curcumin market size & share analysis report (2028) https:\/\/www.grandviewresearch.com\/industry-analysis\/turmeric-extract-curcumin-market.\u00a0Accessed 27 02 2024"},{"key":"4392_CR23","unstructured":"Commission Regulation (EU) 2018\/1556. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=uriserv:OJ.L_.2018.261.01.0006.01.ENG&toc=OJ:L:2018:261:TOC. Accessed\u00a0 27 03 2024"},{"issue":"5","key":"4392_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/0269881114552744","volume":"29","author":"KHM Cox","year":"2015","unstructured":"Cox KHM et al (2015) Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol 29(5):642\u2013651. https:\/\/doi.org\/10.1177\/0269881114552744","journal-title":"J Psychopharmacol"},{"issue":"9","key":"4392_CR25","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/nu11092147","volume":"11","author":"M Dei Cas","year":"2019","unstructured":"Dei Cas M et al (2019) Dietary curcumin: correlation between bioavailability and health potential. Nutrients 11(9):2147. https:\/\/doi.org\/10.3390\/nu11092147","journal-title":"Nutrients"},{"key":"4392_CR26","unstructured":"Dir 2002\/46\/EC. Directive 2002\/46\/EC of the European Parliament and of the Council. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/ALL\/?uri=celex%3A32002L0046. Accessed on 26 03 2024"},{"key":"4392_CR27","doi-asserted-by":"crossref","unstructured":"Domenico Gallina et al (2024) \u201cA Complex Case of Severe Acute Hepatitis with Cholestasis in a Genetically Predisposed Woman: Could Curcumin Be the Trigger?\u201d Journal of Clinical Images and Medical Case Reports. Vol. 5. https:\/\/www.doi.org\/10.52768\/2766-7820\/2850","DOI":"10.52768\/2766-7820\/2850"},{"key":"4392_CR28","unstructured":"DSHEA (1994). Dietary Supplement Health and Education Act, Pub. L. No. 103\u2013417, 108 Stat. 4325, 21 U.S.C. \u00a7 321(ff)(2)(B). https:\/\/www.congress.gov\/bill\/103rd-congress\/senate-bill\/784"},{"key":"4392_CR29","unstructured":"EU Register of Health Claims (n.d.) https:\/\/ec.europa.eu\/food\/food-feed-portal\/screen\/health-claims\/eu-register. Accessed on 27 03 2024"},{"key":"4392_CR30","unstructured":"European Medicines Agency (2018) Draft assessment report on\u00a0Curcuma longa\u00a0L.,\u00a0C. domestica\u00a0Valeton, Rhizome (Revision 1). https:\/\/www.ema.europa.eu\/en\/documents\/herbal-report\/draft-assessment-report-curcuma-longa-l-c-domestica-valeton-rhizome-revision-1_en.pdf. Accessed on 7th December 2024."},{"key":"4392_CR31","unstructured":"Food Safety and Standards Regulations (FSSR) (2016)\u00a0https:\/\/fssai.gov.in\/upload\/uploadfiles\/files\/Nutraceuticals_Regulations.pdf. Accessed 27 03 2023"},{"key":"4392_CR32","unstructured":"Food Supplements Regulations (FSR) 2003: The Food Supplements (England) Regulations 2003 SI 2003 No. 1387, The Food Supplements (Scotland) Regulations 2003 SSI 2003 No. 278, The Food Supplements (Wales) Regulations 2003 WSI 2003 No. 1719 (W186), The Food Supplements (Northern Ireland) Regulations 2003 Statutory Rule 2003 No. 273\u00a0.Accessed 26 03 2024"},{"key":"4392_CR33","doi-asserted-by":"publisher","first-page":"175003","DOI":"10.1016\/j.scitotenv.2024.175003","volume":"949","author":"JE Forsyth","year":"2024","unstructured":"Forsyth JE et al (2024) Evidence of turmeric adulteration with lead chromate across South Asia. Sci Total Environ 949:175003. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.175003","journal-title":"Sci Total Environ"},{"issue":"1","key":"4392_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.fct.2006.07.016","volume":"45","author":"S Ganiger","year":"2007","unstructured":"Ganiger S et al (2007) A two generation reproductive toxicity study with curcumin, turmeric yellow. Wistar Rats Food Chem Toxicol 45(1):64\u201369. https:\/\/doi.org\/10.1016\/j.fct.2006.07.016","journal-title":"Wistar Rats Food Chem Toxicol"},{"key":"4392_CR35","doi-asserted-by":"publisher","unstructured":"Ghosh (2014) Complementary medicine regulation in Australia. Nutraceutical and Functional Food Regulations in the United States and around the World, pp. 301\u2013308, www.sciencedirect.com\/science\/article\/pii\/B9780124058705000177, https:\/\/doi.org\/10.1016\/B978-0-12-405870-5.00017-7.","DOI":"10.1016\/B978-0-12-405870-5.00017-7"},{"issue":"5","key":"4392_CR36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ajh.23159","volume":"87","author":"T Golombick","year":"2012","unstructured":"Golombick T et al (2012) Curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am J Hematol 87(5):455\u2013460. https:\/\/doi.org\/10.1002\/ajh.23159","journal-title":"Am J Hematol"},{"key":"4392_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2147\/JIR.S291293","volume":"14","author":"K Gouthamchandra","year":"2021","unstructured":"Gouthamchandra K et al (2021) Efficacy of a standardized turmeric extract comprised of 70% bisdemothoxy- curcumin (REVERC3) against LPS-induced inflammation in RAW264.7 cells and carrageenan-induced paw edema. J Inflamm Res 14:859\u2013868. https:\/\/doi.org\/10.2147\/JIR.S291293","journal-title":"J Inflamm Res"},{"key":"4392_CR38","unstructured":"GRN No. 822 (n.d). GRAS Notice No. 822. https:\/\/www.fda.gov\/food\/gras-notice-inventory\/recently-published-gras-notices-and-fda-letters. Accessed 27 03 2024"},{"issue":"4","key":"4392_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00280-018-3654-0","volume":"82","author":"R Greil","year":"2018","unstructured":"Greil R et al (2018) A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc\u2122) in patients with locally advanced or metastatic cancer. Cancer Chemother Pharmacol 82(4):695\u2013706. https:\/\/doi.org\/10.1007\/s00280-018-3654-0","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"4392_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.amjmed.2022.09.026","volume":"136","author":"D Halegoua-DeMarzio","year":"2023","unstructured":"Halegoua-DeMarzio D et al (2023) Liver injury associated with turmeric\u2014a growing problem: ten cases from the drug-induced liver injury network [DILIN]. Am J Med 136(2):200\u2013206. https:\/\/doi.org\/10.1016\/j.amjmed.2022.09.026","journal-title":"Am J Med"},{"issue":"8","key":"4392_CR41","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1073\/pnas.1016217108","volume":"108","author":"A Hassaninasab","year":"2011","unstructured":"Hassaninasab A et al (2011) Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc Natl Acad Sci 108(8):4055\u20134060. https:\/\/doi.org\/10.1073\/pnas.1016217108","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"4392_CR42","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00277-020-04379-7","volume":"100","author":"S Hatairaktham","year":"2021","unstructured":"Hatairaktham et al (2021) Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in \u03b2-thalassemia\/Hb E patients. Ann Hematol 100(4):891\u2013901. https:\/\/doi.org\/10.1007\/s00277-020-04379-7","journal-title":"Ann Hematol"},{"issue":"12","key":"4392_CR43","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1021\/acsomega.2c07326","volume":"8","author":"Hegde","year":"2023","unstructured":"Hegde et al (2023) Curcumin formulations for better bioavailability: what we learned from clinical trials thus far? ACS Omega 8(12):10713\u201310746. https:\/\/doi.org\/10.1021\/acsomega.2c07326","journal-title":"ACS Omega"},{"issue":"10","key":"4392_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ et al (2017) Curcumin: a review of its effects on human health. Foods 6(10):92. https:\/\/doi.org\/10.3390\/foods6100092","journal-title":"Foods"},{"key":"4392_CR45","unstructured":"Indena (2019) Meriva\u00ae: food supplement formulation \u2013 safety and efficacy information sheet [PDF]. https:\/\/www.indena.com\/indena_files\/2019\/12\/meriva_ss_int.pdf. Accessed 8 Jun 2025"},{"issue":"6","key":"4392_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.joim.2018.07.001","volume":"16","author":"R Jamwal","year":"2018","unstructured":"Jamwal R et al (2018) Bioavailable curcumin formulations: a review of pharmacokinetic studies in healthy volunteers. J Integr Med 16(6):367\u2013374. https:\/\/doi.org\/10.1016\/j.joim.2018.07.001","journal-title":"J Integr Med"},{"issue":"10","key":"4392_CR47","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/1756-185X.13688","volume":"22","author":"M Javadi","year":"2019","unstructured":"Javadi M et al (2019) Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis. Int J Rheum Dis 22(10):1857\u20131862. https:\/\/doi.org\/10.1111\/1756-185X.13688","journal-title":"Int J Rheum Dis"},{"key":"4392_CR48","first-page":"55","volume":"52","author":"JECFA","year":"2004","unstructured":"JECFA (2004) Safety evaluation of certain food additives and contaminants. Prepared by the 61st meeting of JECFA. WHO Food Additive Series 52:55\u201360 (WHO)","journal-title":"WHO Food Additive Series"},{"issue":"1","key":"4392_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00280-011-1673-1","volume":"69","author":"M Kanai","year":"2012","unstructured":"Kanai M et al (2012) Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol 69(1):65\u201370. https:\/\/doi.org\/10.1007\/s00280-011-1673-1","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"4392_CR50","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00280-013-2151-8","volume":"71","author":"k Kanai","year":"2013","unstructured":"Kanai k et al (2013) A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer chemotherapy and pharmacology 71(6):1521\u20131530. https:\/\/doi.org\/10.1007\/s00280-013-2151-8","journal-title":"Cancer chemotherapy and pharmacology"},{"issue":"6","key":"4392_CR51","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1002\/jcp.26249","volume":"233","author":"F Keihanian","year":"2017","unstructured":"Keihanian F et al (2017) Curcumin, hemostasis, thrombosis, and coagulation. J Cell Physiol 233(6):4497\u20134511. https:\/\/doi.org\/10.1002\/jcp.26249","journal-title":"J Cell Physiol"},{"issue":"46","key":"4392_CR52","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.4103\/0973-1296.182168","volume":"12","author":"k Khatri","year":"2016","unstructured":"Khatri k et al (2016) Kinetics of inhibition of monoamine oxidase using curcumin and ellagic acid. Pharmacognosy Magazine 12(46):S116\u2013S120. https:\/\/doi.org\/10.4103\/0973-1296.182168","journal-title":"Pharmacognosy Magazine"},{"key":"4392_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02825-7","author":"MA Khosravi","year":"2023","unstructured":"Khosravi MA, Seifert R (2023) Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02825-7","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"4","key":"4392_CR54","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5483\/bmbrep.2012.45.4.221","volume":"45","author":"DC Kim","year":"2012","unstructured":"Kim DC et al (2012) Anticoagulant activities of curcumin and its derivative.\u00a0Korean Society for Biochemistry and Molecular Biology. BMB Rep 45(4):221\u2013226. https:\/\/doi.org\/10.5483\/bmbrep.2012.45.4.221","journal-title":"BMB Rep"},{"key":"4392_CR55","doi-asserted-by":"publisher","first-page":"458592","DOI":"10.1155\/2014\/458592","volume":"2014","author":"U Klickovic","year":"2014","unstructured":"Klickovic U et al (2014) Human pharmacokinetics of high dose oral curcumin and its effect on heme oxygenase-1 expression in healthy male subjects. Biomed Res Int 2014:458592. https:\/\/doi.org\/10.1155\/2014\/458592","journal-title":"Biomed Res Int"},{"issue":"2","key":"4392_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/foods8020053","volume":"8","author":"RR Kotha","year":"2019","unstructured":"Kotha RR et al (2019) Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Foods 8(2):53. https:\/\/doi.org\/10.3390\/foods8020053","journal-title":"Foods"},{"issue":"1","key":"4392_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1079\/BJN19790012","volume":"41","author":"L Latif","year":"1979","unstructured":"Latif L et al (1979) Toxicity of shoti (Indian arrowroot: Curcuma zedoaria) for rats and chicks. British Journal of Nutrition 41(1):57\u201363. https:\/\/doi.org\/10.1079\/BJN19790012","journal-title":"British Journal of Nutrition"},{"issue":"4","key":"4392_CR58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/(SICI)1099-1573(199906)13:4<318::AID-PTR445>3.0.CO;2-7","volume":"13","author":"B Lal","year":"1999","unstructured":"Lal B et al (1999) Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res: PTR 13(4):318\u2013322. https:\/\/doi.org\/10.1002\/(SICI)1099-1573(199906)13:4%3c318::AID-PTR445%3e3.0.CO;2-7","journal-title":"Phytother Res: PTR"},{"key":"4392_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6882-6-10","volume":"6","author":"CD Lao","year":"2006","unstructured":"Lao CD et al (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10. https:\/\/doi.org\/10.1186\/1472-6882-6-10","journal-title":"BMC Complement Altern Med"},{"key":"4392_CR60","doi-asserted-by":"publisher","unstructured":"Lee et al (2020) Autoimmune hepatitis associated with turmeric consumption. ACG Case Rep J 7(3):e00320. journals.lww.com\/acgcr\/fulltext\/2020\/03000\/autoimmune_hepatitis_associated_with_turmeric.1.aspx, https:\/\/doi.org\/10.14309\/crj.0000000000000320","DOI":"10.14309\/crj.0000000000000320"},{"key":"4392_CR61","unstructured":"LifeExtension (2020) New survey reveals 74 percent of Americans are concerned that vitamins and supplements are not backed by trustworthy research. www.prnewswire.com, www.prnewswire.com\/news-releases\/new-survey-reveals-74-percent-of-americans-are-concerned-that-vitamins-and-supplements-are-not-backed-by-trustworthy-research-301073158.html. Accessed 14th March 2024"},{"issue":"3","key":"4392_CR62","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bcp.14460","volume":"87","author":"N Lombardi","year":"2020","unstructured":"Lombardi N et al (2020) Acute liver injury following turmeric use in Tuscany: an analysis of the Italian phytovigilance database and systematic review of case reports. Brit J Clin Pharmacol 87(3):741\u2013753. https:\/\/doi.org\/10.1111\/bcp.14460","journal-title":"Brit J Clin Pharmacol"},{"key":"4392_CR63","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jad.2014.06.001","volume":"167","author":"AL Lopresti","year":"2014","unstructured":"Lopresti et al (2014) Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord 167:368\u2013375. https:\/\/doi.org\/10.1016\/j.jad.2014.06.001","journal-title":"J Affect Disord"},{"key":"4392_CR64","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jad.2016.09.047","volume":"207","author":"AL Lopresti","year":"2017","unstructured":"Lopresti et al (2017) Efficacy of curcumin, and a saffron\/curcumin combination for the treatment of major depression: a randomised, double-blind, placebo-controlled study. J Affect Disord 207:188\u2013196. https:\/\/doi.org\/10.1016\/j.jad.2016.09.047","journal-title":"J Affect Disord"},{"key":"4392_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6741213","volume":"2019","author":"RP Luber","year":"2019","unstructured":"Luber RP et al (2019) Turmeric induced liver injury: a report of two cases. Case Rep Hepatol 2019:1\u20134. https:\/\/doi.org\/10.1155\/2019\/6741213","journal-title":"Case Rep Hepatol"},{"key":"4392_CR66","doi-asserted-by":"crossref","unstructured":"Lukefahr et al (2018) Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use, BMJ Case Reports. Available at: https:\/\/casereports.bmj.com\/content\/2018\/bcr-2018-224611.citation-tools. Accessed 23 Sep 2024)","DOI":"10.1136\/bcr-2018-224611"},{"issue":"6","key":"4392_CR67","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00776-014-0633-0","volume":"19","author":"Y Nakagawa","year":"2014","unstructured":"Nakagawa Y et al (2014b) Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthopaedic Sci: Off J Jpn Orthop Assoc 19(6):933\u2013939. https:\/\/doi.org\/10.1007\/s00776-014-0633-0","journal-title":"J Orthopaedic Sci: Off J Jpn Orthop Assoc"},{"issue":"6","key":"4392_CR68","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00776-014-0633-0","volume":"19","author":"Y Nakagawa","year":"2014","unstructured":"Nakagawa Y et al (2014a) Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis. J Orthop Sci 19(6):933\u2013939. https:\/\/doi.org\/10.1007\/s00776-014-0633-0","journal-title":"J Orthop Sci"},{"key":"4392_CR69","unstructured":"Nutrition and Health Claims Register (NHC) (n.d.) https:\/\/www.gov.uk\/government\/publications\/great-britain-nutrition-and-health-claims-nhc-register   . accessed on 28 03 2024"},{"issue":"3","key":"4392_CR70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/FJC.0000000000000406","volume":"68","author":"Y Panahi","year":"2016","unstructured":"Panahi Y et al (2016) Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol 68(3):223\u2013229. https:\/\/doi.org\/10.1097\/FJC.0000000000000406","journal-title":"J Cardiovasc Pharmacol"},{"key":"4392_CR71","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.toxrep.2021.06.008","volume":"8","author":"V Pancholi","year":"2021","unstructured":"Pancholi V et al (2021) Safety assessment of a highly bioavailable curcumin-galactomannoside complex (CurQfen) in healthy volunteers, with a special reference to the recent hepatotoxic reports of curcumin supplements: a 90-days prospective study. Toxicol Rep 8:1255\u20131264. https:\/\/doi.org\/10.1016\/j.toxrep.2021.06.008","journal-title":"Toxicol Rep"},{"key":"4392_CR72","doi-asserted-by":"crossref","unstructured":"Prasad et al (2011). Turmeric, the golden spice: From traditional medicine to modern medicine. In I. F. F. Benzie & S. Wachtel-Galor (Eds.), Herbal medicine: Biomolecular and clinical aspects (2nd ed., Chapter 13). Boca Raton, FL: CRC Press\/Taylor & Francis. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92752","DOI":"10.1201\/b10787-14"},{"issue":"3","key":"4392_CR73","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/plants12030623","volume":"12","author":"JM Prieto-Garcia","year":"2023","unstructured":"Prieto-Garcia JM et al (2023) Potential pharmacokinetic interactions of common cardiovascular drugs and selected European and Latin American herbal medicines: a scoping review. Plants 12(3):623. https:\/\/doi.org\/10.3390\/plants12030623","journal-title":"Plants"},{"issue":"13","key":"4392_CR74","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1021\/acs.jafc.6b00053","volume":"64","author":"P Qiu","year":"2016","unstructured":"Qiu et al (2016) Overdose intake of curcumin initiates the unbalanced state of bodies. J Agric Food Chem 64(13):2765\u20132771. https:\/\/doi.org\/10.1021\/acs.jafc.6b00053","journal-title":"J Agric Food Chem"},{"issue":"4","key":"4392_CR75","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1440-6047.2002.00296.x","volume":"11","author":"A Rasyid","year":"2002","unstructured":"Rasyid et al (2002) Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr 11(4):314\u2013318. https:\/\/doi.org\/10.1046\/j.1440-6047.2002.00296.x","journal-title":"Asia Pac J Clin Nutr"},{"key":"4392_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03050-6","author":"AM Rathmann","year":"2024","unstructured":"Rathmann AM, Seifert R (2024) Vitamin A-containing dietary supplements from German and US online pharmacies: market and risk assessment. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03050-6. (Advanceonlinepublication.doi:10.1007\/s00210-024-03050-6)","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"4392_CR77","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.pbb.2011.05.011","volume":"99","author":"KH Reeta","year":"2011","unstructured":"Reeta KH et al (2011) Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Pharmacol Biochem Behav 99(3):399\u2013407. https:\/\/doi.org\/10.1016\/j.pbb.2011.05.011","journal-title":"Pharmacol Biochem Behav"},{"key":"4392_CR78","unstructured":"Reg. EU 1924\/2006. Regulation (EC) No 1924\/2006 of the European Parliament and of the Council. https:\/\/eur-lex.europa.eu\/legal-content\/en\/ALL\/?uri=CELEX%3A32006R1924. Accessed\u00a0 27 03 2024"},{"key":"4392_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2019.05.001","volume":"69","author":"P Sarraf","year":"2019","unstructured":"Sarraf P et al (2019) Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Res 69:1\u20138. https:\/\/doi.org\/10.1016\/j.nutres.2019.05.001","journal-title":"Nutr Res"},{"issue":"3","key":"4392_CR80","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/mnfr.201300724","volume":"58","author":"C Schiborr","year":"2014","unstructured":"Schiborr C et al (2014) The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res 58(3):516\u2013527. https:\/\/doi.org\/10.1002\/mnfr.201300724","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"4392_CR81","first-page":"1894","volume":"7","author":"RA Sharma","year":"2001","unstructured":"Sharma RA et al (2001) Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin Cancer Res 7(7):1894\u20131900","journal-title":"Clin Cancer Res"},{"issue":"16","key":"4392_CR82","doi-asserted-by":"publisher","first-page":"e19723","DOI":"10.1097\/MD.0000000000019723","volume":"99","author":"D Shep","year":"2020","unstructured":"Shep et al (2020) Efficacy and safety of combination of curcuminoid complex and diclofenac versus diclofenac in knee osteoarthritis: a randomized trial. Med 99(16):e19723. https:\/\/doi.org\/10.1097\/MD.0000000000019723","journal-title":"Med"},{"issue":"12","key":"4392_CR83","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/pharmaceutics13122102","volume":"13","author":"SI Sohn","year":"2021","unstructured":"Sohn SI et al (2021) Biomedical applications and bioavailability of curcumin\u2014an updated overview. Pharmaceutics 13(12):2102. https:\/\/doi.org\/10.3390\/pharmaceutics13122102","journal-title":"Pharmaceutics"},{"issue":"3","key":"4392_CR84","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2105\/AJPH.2014.302348","volume":"105","author":"RR Starr","year":"2015","unstructured":"Starr RR (2015) Too little, too late: ineffective regulation of dietary supplements in the United States. Am J Public Health 105(3):478\u201385. https:\/\/doi.org\/10.2105\/AJPH.2014.302348","journal-title":"Am J Public Health"},{"issue":"6","key":"4392_CR85","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/molecules25061397","volume":"25","author":"SJ Stohs","year":"2020","unstructured":"Stohs SJ et al (2020) Highly bioavailable forms of curcumin and promising avenues for curcumin-based research and application: a review. Mol 25(6):1397. https:\/\/doi.org\/10.3390\/molecules25061397","journal-title":"Mol"},{"issue":"1","key":"4392_CR86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5414\/CP202076","volume":"53","author":"A Storka","year":"2015","unstructured":"Storka A et al (2015) Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans. Int J Clin Pharmacol Ther 53(1):54\u201365. https:\/\/doi.org\/10.5414\/CP202076","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"4392_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3177\/jnsv.61.37","volume":"61","author":"Y Sunagawa","year":"2015","unstructured":"Sunagawa Y et al (2015) Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study. J Nutr Sci Vitaminol 61(1):37\u201344. https:\/\/doi.org\/10.3177\/jnsv.61.37","journal-title":"J Nutr Sci Vitaminol"},{"issue":"14","key":"4392_CR88","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3390\/molecules24142527","volume":"24","author":"BL Tan","year":"2019","unstructured":"Tan BL et al (2019) Curcumin combination chemotherapy: the implication and efficacy in cancer. Mol (Basel, Switzerland) 24(14):2527. https:\/\/doi.org\/10.3390\/molecules24142527","journal-title":"Mol (Basel, Switzerland)"},{"key":"4392_CR89","unstructured":"TGA (2023a) Medicines containing turmeric or curcumin - risk of liver injury. Therapeutic Goods Administration (TGA), www.tga.gov.au\/news\/safety-alerts\/medicines-containing-turmeric-or-curcumin-risk-liver-injury. Accessed 14 Mar 2024"},{"key":"4392_CR90","unstructured":"TGA (2023b) Medicines containing turmeric or curcumin - risk of liver injury. Therapeutic Goods Administration (TGA), www.tga.gov.au\/news\/safety-alerts\/medicines-containing-turmeric-or-curcumin-risk-liver-injury. Accessed 2 04 2024"},{"key":"4392_CR91","unstructured":"Permissible Indications Determination (2021) Therapeutic Goods (Permissible Indications) Determination (No. 1) 2021. https:\/\/www.legislation.gov.au\/F2021L00056\/asmade\/text. Accessed 27 03 2024"},{"key":"4392_CR92","unstructured":"Therapeutic Goods Regulations (TGR) 1990. https:\/\/www.legislation.gov.au\/F1996B00406\/2022-03-31\/text. Accessed 2 04 2024"},{"issue":"1","key":"4392_CR93","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1038\/s41598-018-32032-x","volume":"8","author":"RN Thota","year":"2018","unstructured":"Thota RN et al (2018) Curcumin alleviates postprandial glycaemic response in healthy subjects: a cross-over, randomized controlled study. Sci Rep 8(1):13679. https:\/\/doi.org\/10.1038\/s41598-018-32032-x","journal-title":"Sci Rep"},{"issue":"1","key":"4392_CR94","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/antiox10010126","volume":"10","author":"G Tossetta","year":"2021","unstructured":"Tossetta G et al (2021) The multifaced actions of curcumin in pregnancy outcome. Antioxidants (Basel, Switzerland) 10(1):126. https:\/\/doi.org\/10.3390\/antiox10010126","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"4392_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02602-6","author":"M Trabert","year":"2024","unstructured":"Trabert M et al (2024) Critical analysis of ginkgo preparations: comparison of approved drugs and dietary supplements marketed in Germany. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02602-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4392_CR96","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2903\/j.efsa.2017.4774","volume":"15","author":"D Turck","year":"2017","unstructured":"Turck D et al (2017) Curcumin and normal functioning of joints: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No\u00a01924\/2006. EFSA J 15:5. https:\/\/doi.org\/10.2903\/j.efsa.2017.4774","journal-title":"EFSA J"},{"key":"4392_CR97","unstructured":"TGO No. 92 (n.d). Therapeutic Goods Order (TGO) No. 92 - standard for labels of non-prescription medicines. https:\/\/www.legislation.gov.au\/F2016L01287\/latest. Accessed 27 03 2024"},{"key":"4392_CR98","unstructured":"Theravalues Corporation (n.d.) Theracurmin\u00ae bioavailable curcumin powder.https:\/\/www.theravalues.com\/our-products\/theracurmin\/. Accessed 8 Jun 2025"},{"issue":"3","key":"4392_CR99","doi-asserted-by":"publisher","first-page":"e0121313","DOI":"10.1371\/journal.pone.0121313","volume":"10","author":"P Tyagi","year":"2015","unstructured":"Tyagi P et al (2015) Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS ONE 10(3):e0121313. https:\/\/doi.org\/10.1371\/journal.pone.0121313","journal-title":"PLoS ONE"},{"key":"4392_CR100","doi-asserted-by":"publisher","first-page":"725362","DOI":"10.3389\/fphar.2021.725362","volume":"12","author":"P Wang","year":"2021","unstructured":"Wang P et al (2021) Comparing the effect of piperine and ilepcimide on the pharmacokinetics of curcumin in SD rats. Front Pharmacol 12:725362. https:\/\/doi.org\/10.3389\/fphar.2021.725362","journal-title":"Front Pharmacol"},{"key":"4392_CR101","unstructured":"Warning Letters: Curcumin (n.d.) (search term). US Food and Drug Administration. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/compliance-actions-and-activities\/warning-letters. Accessed 28 03 2024"},{"key":"4392_CR102","unstructured":"Yadav et al (2017) Phytochemical screening, antioxidant activity, and cytotoxicity potential of turmeric (Curcuma longa Linn) extracts. Int J Phytomed 6(1):17\u2013211. https:\/\/www.phytojournal.com\/archives\/2017\/vol6issue1\/PartA\/6-1-17-211.pdf"},{"issue":"1\u20132","key":"4392_CR103","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jchromb.2007.03.010","volume":"853","author":"KY Yang","year":"2007","unstructured":"Yang et al (2007) Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC\u2013MS\/MS. J Chromatogr B 853(1\u20132):183\u2013189. https:\/\/doi.org\/10.1016\/j.jchromb.2007.03.010","journal-title":"J Chromatogr B"},{"key":"4392_CR104","doi-asserted-by":"publisher","first-page":"131007","DOI":"10.1016\/j.foodchem.2021.131007","volume":"370","author":"H You","year":"2022","unstructured":"You et al (2022) Analytical strategies to determine the labelling accuracy and economically-motivated adulteration of \u201cnatural\u201d dietary supplements in the marketplace: turmeric case study. Food Chem 370:131007. https:\/\/doi.org\/10.1016\/j.foodchem.2021.131007","journal-title":"Food Chem"},{"key":"4392_CR105","doi-asserted-by":"publisher","first-page":"643119","DOI":"10.3389\/fphar.2021.643119","volume":"12","author":"I Yuandani","year":"2021","unstructured":"Yuandani et al (2021) Immunomodulatory effects and mechanisms of curcuma species and their bioactive compounds: a review. Front Pharmacol 12:643119. https:\/\/doi.org\/10.3389\/fphar.2021.643119","journal-title":"Front Pharmacol"},{"issue":"5","key":"4392_CR106","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/advances\/nmz033","volume":"10","author":"F Yuan","year":"2019","unstructured":"Yuan et al (2019) A systematic review and meta-analysis of randomized controlled trials on the effects of turmeric and curcuminoids on blood lipids in adults with metabolic diseases. Adv Nutr 10(5):791\u2013802. https:\/\/doi.org\/10.1093\/advances\/nmz033","journal-title":"Adv Nutr"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04392-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04392-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04392-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:03:19Z","timestamp":1771538599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04392-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4392"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04392-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.R.-M. declares no conflict of interest. R.S. is the Editor-in-Chief of Naunyn-Schmiedebergs Arch Pharmacol and follows the editorial guidelines of editors acting as editors (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable, as publicly available information is used as a data source.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This work was carried out in accordance with the guidelines of good scientific practice of Hannover Medical School (\n                      \n                      ) and officially registered as a doctoral project for Haleema Rahim-Mahdy. Hannover Medical School follows the guidelines of the German Research Foundation (DFG).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study did not involve human participants directly. The analysis was based solely on publicly available data from freely accessible supplement information sources.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}